SAMHD1 downregulation on the mRNA and protein level, compared to CD4+ T-cells from healthy donors or monocytic THP-1 cells, was also observed in various CD4+ T-cell lines derived from leukemia and CTCL patients [72, 73]. This evidence concerns the gene SAMHD1 and leukemia.